Literature DB >> 719574

Bilateral carcinoma of the breast: frequency and mortality.

C B Mueller, F Ames.   

Abstract

Of 3558 women with cancer of the breast, 129 were found to have bilateral primary cancers. In approximately one quarter (33) of these women the two cancers developed synchronously; in the remainder (96) the second cancer developed metachronously, more than 6 months after the appearance of the first primary tumour. In two thirds (64) of the women in the latter group the second cancer made its appearance within 4 years after the first was detected. The 15-year survival curve for the 129 patients shows a 50% mortality at approximately 10 years, slightly better than that for the total group of 3558. At the time of our study (April 1975) 70 were alive and 59 were dead; 53 died as a result of their breast cancer and 6 from other causes. Only 3 of the 48 women in whom the first cancer developed before the age of 70 years died of causes other than breast cancer, giving a mortality due to breast cancer of 90%. The clinical stage, the recorded histopathology, the type of operation and the duration of time at risk after the first diagnosis did not differ significantly between those who lived and those who died. The authors conclude that age, stage or type of growth, operative therapy or time at risk do not determine the time of death or alter the 90% certainty that death will be due to carcinoma of the breast.

Entities:  

Mesh:

Year:  1978        PMID: 719574

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  13 in total

1.  First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer.

Authors:  Tabassum Wadasadawala; Shanu Jain; Siji Paul; Reena Phurailatpam; Kishore Joshi; Palak Popat; Sandip Tandon; Aruna Alahari; Rajiv Sarin
Journal:  Br J Radiol       Date:  2017-07-14       Impact factor: 3.039

2.  Bilateral breast cancer: one disease or two?

Authors:  P J Dawson; T Maloney; P Gimotty; P Juneau; H Ownby; S R Wolman
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

3.  Breast cancer.

Authors: 
Journal:  Can Med Assoc J       Date:  1983-11-01       Impact factor: 8.262

4.  Primary bilateral breast cancer.

Authors:  E B Smith
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

5.  Follow-up design of unexpected enhancing lesions on preoperative MRI of breast cancer patients.

Authors:  Joo Yeon Cheung; Jin Hee Moon
Journal:  Diagn Interv Radiol       Date:  2015 Jan-Feb       Impact factor: 2.630

6.  Prognostic significance of synchronous and metachronous bilateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

7.  Use of tomotherapy in treatment of synchronous bilateral breast cancer: dosimetric comparison study.

Authors:  T Wadasadawala; B Visariya; R Sarin; R R Upreti; S Paul; R Phurailatpam
Journal:  Br J Radiol       Date:  2015-01-21       Impact factor: 3.039

8.  Adjuvant chemotherapy of breast cancer: hope--reality--hazard?

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1984-02-15

9.  Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1981-08-03

10.  How breast cancer presents.

Authors:  J E Devitt
Journal:  Can Med Assoc J       Date:  1983-07-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.